KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Non Operating Income (2016 - 2026)

Pacific Biosciences Of California has reported Non Operating Income over the past 16 years, most recently at $2.8 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 31.91% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $14.8 million, down 37.95%, while the annual FY2025 figure was $14.8 million, 37.95% down from the prior year.
  • Non Operating Income for Q4 2025 was $2.8 million at Pacific Biosciences Of California, down from $3.0 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $8.9 million in Q2 2023 and troughed at -$279000.0 in Q1 2022.
  • A 5-year average of $4.2 million and a median of $4.3 million in 2025 define the central range for Non Operating Income.
  • On a YoY basis, Non Operating Income climbed as much as 634700.0% in 2022 and fell as far as 535.94% in 2022.
  • Year by year, Non Operating Income stood at $1000.0 in 2021, then surged by 634700.0% to $6.3 million in 2022, then surged by 32.06% to $8.4 million in 2023, then tumbled by 51.51% to $4.1 million in 2024, then crashed by 31.91% to $2.8 million in 2025.
  • Business Quant data shows Non Operating Income for PACB at $2.8 million in Q4 2025, $3.0 million in Q3 2025, and $4.7 million in Q2 2025.